4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-055174
EVP & Chief Tech Ops Officer sold 262 shares at $88.00 ($23,056)
From the SEC's structured data for this filing
Trades in this filing
Huang Dennis Karl · EVP & Chief Tech Ops Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-10-14 | Sale : show line 1 in the form | −262 | $88.00 | $23,056 | 34,699 | D |
| Open-market sales · 262 sh · avg $88.00 · $23,056 | ||||||
Loading xslF345X03/doc4.xml…